Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on October 25, 2025
LiTime Showcases Reliable Lithium Solutions at Equip Exposition, Powering the Fuel-to-Electric Transition in Landscaping Equipment
LOUISVILLE, Ky., Oct. 25, 2025 (GLOBE NEWSWIRE) -- LiTime, a global pioneer in energy innovation, showcased its latest lithium power solutions for landscaping and outdoor applications at Equip Exposition 2025 (Booth No. 10006), one of North America’s …
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal reflux disease (GERD) symptoms in patients treated with VOQUEZNA, including clinically meaningful increases in heartburn-free nights …
DeFi Crypto Mutuum Finance Completes Phase 1 Roadmap as V1 Protocol Launch Approaches
Dubai, UAE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market begins shifting its focus back to fundamentals, one new crypto project is standing out for its steady progress and structured delivery. Mutuum Finance (MUTM) has been methodically …
New Crypto Mutuum Finance (MUTM) Nears V1 Launch After Raising Over $17.8M
Dubai, UAE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- In a market where many blockchain projects promise innovation but struggle with execution, Mutuum Finance (MUTM) is quickly emerging as one of the top crypto demonstrating steady, measurable progress. The …
DebitMyData מספקת פתרון למשבר איסור היצוא העולמי של H20, חושפת את התפקיד הקריטי של Human Energy Grid
Human Energy Grid של DebitMyData פורט לודרדייל, פלורידה, Oct. 25, 2025 (GLOBE NEWSWIRE) -- DebitMyData™, Inc פרסמה עדכון חשוב עבור בעלי עניין גלובליים ולציבור הדיגיטלי בתגובה לאיסורי היצוא ובקרות הסחר האחרונות בהיבט של H20, המשפיעים על חדשנות בתחום הבינה …
Tussentijdse gegevens van Merus over petosemtamab bij gemetastaseerde colorectale kanker tonen monotherapie-activiteit en robuust responspercentage aan in combinatie met FOLFOX/FOLFIRI, alsook goed verdragen veiligheid
– 100% responspercentage in 1L linkszijdige mCRC (n=8, bevestigd en onbevestigd) – 62% responspercentage in 2L links- en rechtszijdige mCRC (n=13, bevestigd en onbevestigd) UTRECHT, Nederland en CAMBRIDGE, Massachusetts, Oct. 25, 2025 (GLOBE NEWSWIRE) -- …
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data from its Phase 3 COMPETE trial in patients with Grade 1 or Grade 2 somatostatin receptor (SSTR)-positive …